Roger Mills

Roger Mills

Chief Tech/Sci/R&D Officer at ADDEX THERAPEUTICS LTD

Net worth: 26 071 $ as of 30/08/2026

69 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Roger G.
Mills
, MD, is a Non-Executive Director & Chief Medical Officer at Addex Therapeutics Ltd. and a Director & Executive Vice President at San Diego Opera.
He is on the Board of Directors at Enterin, Inc., Addex Therapeutics Ltd. and San Diego Opera.
Dr. Mills was previously employed as a Chief Medical Officer & Executive VP-Development by ACADIA Pharmaceuticals, Inc., a Principal by Gilead Sciences, Inc., a Vice President-Development by Pfizer (St. Louis), and a Principal by Wellcome Foundation Ltd. He received his doctorate degree from Charing Cross Hospital Medical School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/09/2026 785,976 ( 0.36% ) 26 071 $ 30/08/2026

Roger Mills active positions

CompaniesPositionStart
ADDEX THERAPEUTICS LTD Chief Tech/Sci/R&D Officer 27/11/2016
Director/Board Member -
Director/Board Member 12/09/2021

Former positions of Roger Mills

CompaniesPositionEnd
ACADIA PHARMACEUTICALS INC. Chief Tech/Sci/R&D Officer 03/11/2015
Corporate Officer/Principal -
Corporate Officer/Principal -
GILEAD SCIENCES, INC. Corporate Officer/Principal -
See the detail of Roger Mills's experience

Training of Roger Mills

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

57

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!